Probiotic Fermented Milk Reduced Alzheimer’s Plaques and Boosted Memory in Mice

For someone watching a parent or spouse slide toward Alzheimer's disease, the condition's biology can feel locked away in the brain, out of reach of anything a family can actually change. A new mouse study points to a more approachable lever: the gut. Researchers fed Alzheimer's-model mice a daily dose of skim milk fermented with a single probiotic bacterium, and after two months the treated mice swam more directly toward a hidden platform in memory tests, carried less amyloid plaque in a key brain region, and had calmer inflammation markers, alongside a gut bacteria mix that shifted toward what is normally seen in healthy mice.

Key takeaways:

• A probiotic-fermented milk made with Lacticaseibacillus rhamnosus KF7 was linked to lower amyloid plaque in the brain's cortex and better spatial-memory performance in APP/PS1 mice, a standard Alzheimer's model.
• Treated mice also showed calmer brain inflammation, lower blood levels of inflammatory proteins, and gut bacteria that shifted toward a pattern more like that of healthy mice.
• The strongest gut-chemistry change to survive strict statistical correction was higher activity in secondary bile acid production, a pathway gut bacteria use to turn bile acids into signaling molecules.
• This is mouse-only, preclinical evidence: the hippocampus (the brain region most tied to memory formation) did not show a significant plaque reduction, and whether this probiotic affects human cognition or Alzheimer's is untested.

Probiotic-Fermented Milk Lowers Amyloid Plaques in Alzheimer's Mice

KF7-fermented milk, skim milk fermented with the probiotic bacterium Lacticaseibacillus rhamnosus KF7, was associated with lower amyloid-beta plaque buildup in the brains of APP/PS1 mice, a genetically engineered mouse strain that develops Alzheimer's-like brain pathology, according to a study published in the journal Foods. APP/PS1 mice carry two human genes linked to early-onset Alzheimer's that cause them to accumulate amyloid-beta, a sticky protein fragment that clumps into the plaques considered a hallmark of the disease. After 60 days of daily dosing, mice given KF7-fermented milk had a lower amyloid plaque burden in the cerebral cortex (the brain's outer, wrinkled layer involved in reasoning and memory) than Alzheimer's mice given a saline placebo, a result confirmed by two separate staining methods. A similar pattern has shown up before: in a 2017 study in Scientific Reports, Alzheimer's-model mice raised with no gut bacteria at all developed far less amyloid pathology than mice with a normal microbiome, reinforcing the idea that gut bacteria help set the pace of amyloid buildup.

Why Gut-Based Alzheimer's Research Matters for At-Risk Families

Anyone with a parent, sibling, or spouse diagnosed with Alzheimer's disease, or who is noticing their own memory lapses, has reason to care where this research leads, because current drugs only modestly slow the disease and do not reverse it. The gut-brain connection explored here is part of a larger push: the National Institute on Aging is funding a multi-site effort called the Alzheimer's Gut Microbiome Project to map how intestinal bacteria shape brain aging, and separate NIH-backed research has found that shifts in the human gut microbiome can precede cognitive decline rather than simply follow it. That timing matters: if gut changes come first, there may be a window to intervene before symptoms progress. None of that proves this fermented-milk product helps people, but it is why the mouse result is worth tracking.

Study Design: 30 Mice, 60 Days of Fermented Milk, and a Water Maze

Researchers worked with 30 mice split into four groups: 16 genetically normal mice and 14 APP/PS1 Alzheimer's-model mice, with each genotype further divided into a group getting KF7-fermented milk and a group getting a saline placebo by daily oral dosing (group sizes ranged from 6 to 8 mice). Each dose of fermented milk delivered about 130 million live KF7 bacteria, given once daily for 60 consecutive days. Afterward, the mice swam in a Morris water maze (a circular pool where mice learn the location of a hidden, submerged platform, a standard rodent memory test), with the researcher running the trials, though not the person later analyzing the data, kept unaware of which treatment each mouse had received. Alzheimer's mice given the probiotic milk swam a longer distance and spent more time in the platform's quadrant than Alzheimer's mice given placebo, suggesting improved spatial memory, though the treatment did not improve every measure the researchers tracked in that test.

What the Gut Bacteria and Blood Chemistry Changes Could Mean

Several biological changes accompanied the lower amyloid levels. Alzheimer's mice on the probiotic milk had lower brain levels of glutamate (a neurotransmitter that, in excess, can overactivate and damage neurons) and higher whole-blood levels of serotonin (5-HT, a neurotransmitter largely produced by gut cells and shaped by gut bacteria), alongside lower blood levels of three inflammatory proteins: TNF-alpha, IL-1beta, and IL-6. Brain tissue also showed calmer activity from microglia and astrocytes (the brain's resident immune and support cells, which become overactive around amyloid plaques and are thought to worsen damage) in the cortex. In the gut itself, the probiotic milk was linked to higher activity in the secondary bile acid pathway, the strongest of only two pathway-level changes to survive strict statistical correction for testing many metabolites at once; bile acids are increasingly studied as signaling molecules gut bacteria can use to communicate with the rest of the body. For someone managing a gut condition like IBS or IBD alongside concerns about memory, this is a reason to ask a doctor about gut-brain research generally, not a reason to start dosing with a specific probiotic. No fermented-milk product is an approved or proven Alzheimer's treatment.

Caveats: A Mouse Study With an Unproven Human Benefit

Several limits keep this from translating directly to people. The mice are a genetically engineered Alzheimer's model, not human patients, so the findings need confirmation in human trials before anyone should expect a cognitive benefit. Within the mouse data itself, the amyloid plaque reduction reached statistical significance in the cortex but not in the hippocampus, the brain structure most directly tied to forming new memories, so the benefit was partial rather than disease-wide. The placebo group received saline rather than unfermented milk, so the study cannot separate the effect of the KF7 bacterium itself from the effect of drinking a milk-based liquid at all, a gap the researchers acknowledge directly. Group sizes were also small (6 to 8 mice each), and only male mice were tested, so the results may not generalize to females or to larger populations.

Next Steps: Human-Relevant Dairy Controls and Clinical Trials

The researchers say future work should add an unfermented-milk control group, test both sexes, and track gut bacteria from the start of treatment rather than only at the end, to pin down whether the KF7 bacterium itself, or simply the fermented-milk matrix, drives the effect. A jump from mice to people is not purely hypothetical: a related probiotic strain paired with skim milk already improved memory and naming-test scores in older adults with mild cognitive impairment over a 12-week trial, though this specific KF7 strain has not been tested in people.

Common Questions

Can a fermented-milk probiotic treat or prevent Alzheimer's disease in people? Not based on this study. It tested genetically engineered Alzheimer's-model mice, not human patients, and no probiotic or fermented-milk product is an approved treatment for Alzheimer's disease.

What is Lacticaseibacillus rhamnosus KF7? It is a probiotic bacterium strain isolated from kefir, a traditional fermented milk drink, that researchers used to ferment skim milk before feeding it daily to mice in this study.

Why did the mice's memory improve but not every brain measure? The probiotic milk was linked to a lower amyloid plaque burden and better performance on some water-maze memory measures in the brain's cortex, but the hippocampus (the memory-formation hub) did not show a statistically significant improvement, so the effect was partial.

References

1. Yilin Zhang, Zhenmin Liu, Chunping You (2026). Effects of Lacticaseibacillus rhamnosus KF7-Fermented Milk on Cognitive Function, Gut Microbiota, and Fecal Metabolism in APP/PS1 Mice. Foods. https://doi.org/10.3390/foods15183304
2. T. Harach, N. Marungruang, N. Duthilleul, et al. (2017). Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Scientific Reports. https://doi.org/10.1038/srep41802
3. Beyond the brain: The gut microbiome and Alzheimer's disease. NIH. https://www.nia.nih.gov/news/beyond-brain-gut-microbiome-and-alzheimers-disease
4. Changes in human microbiome precede Alzheimer's cognitive declines. NIH. https://www.nia.nih.gov/news/changes-human-microbiome-precede-alzheimers-cognitive-declines
5. Su-Jin Jung, Kyohee Cho, Eun-Soo Jung, et al. (2025). Augmenting Cognitive Function in the Elderly with Mild Cognitive Impairment Using Probiotic Lacticaseibacillus rhamnosus CBT-LR5: A 12-Week Randomized, Double-Blind, Parallel-Group Non-Comparative Study. Nutrients. https://doi.org/10.3390/nu17040691